These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 29679883)
1. Protective effects of stigmasterol against ketamine-induced psychotic symptoms: Possible behavioral, biochemical and histopathological changes in mice. Yadav M; Parle M; Jindal DK; Dhingra S Pharmacol Rep; 2018 Jun; 70(3):591-599. PubMed ID: 29679883 [TBL] [Abstract][Full Text] [Related]
2. Protective effect of gallic acid in experimental model of ketamine-induced psychosis: possible behaviour, biochemical, neurochemical and cellular alterations. Yadav M; Jindal DK; Dhingra MS; Kumar A; Parle M; Dhingra S Inflammopharmacology; 2018 Apr; 26(2):413-424. PubMed ID: 28577133 [TBL] [Abstract][Full Text] [Related]
3. Potential effect of spermidine on GABA, dopamine, acetylcholinesterase, oxidative stress and proinflammatory cytokines to diminish ketamine-induced psychotic symptoms in rats. Yadav M; Parle M; Jindal DK; Sharma N Biomed Pharmacother; 2018 Feb; 98():207-213. PubMed ID: 29268241 [TBL] [Abstract][Full Text] [Related]
4. Targeting oxidative stress, acetylcholinesterase, proinflammatory cytokine, dopamine and GABA by eucalyptus oil (Eucalyptus globulus) to alleviate ketamine-induced psychosis in rats. Yadav M; Jindal DK; Parle M; Kumar A; Dhingra S Inflammopharmacology; 2019 Apr; 27(2):301-311. PubMed ID: 29464495 [TBL] [Abstract][Full Text] [Related]
5. Antipsychotic and sedative effects of the leaf extract of Crassocephalum bauchiense (Hutch.) Milne-Redh (Asteraceae) in rodents. Sotoing Taïwe G; Ngo Bum E; Talla E; Dawe A; Okomolo Moto FC; Temkou Ngoupaye G; Sidiki N; Dabole B; Djomeni Dzeufiet PD; Dimo T; De Waard M J Ethnopharmacol; 2012 Aug; 143(1):213-20. PubMed ID: 22750453 [TBL] [Abstract][Full Text] [Related]
6. Probable mechanisms involved in the antipsychotic-like activity of methyl jasmonate in mice. Annafi OS; Aluko OM; Eduviere AT; Omorogbe O; Umukoro S Naunyn Schmiedebergs Arch Pharmacol; 2017 Sep; 390(9):883-892. PubMed ID: 28612111 [TBL] [Abstract][Full Text] [Related]
7. Protective effects of Spinacia oleracea seeds extract in an experimental model of schizophrenia: Possible behavior, biochemical, neurochemical and cellular alterations. Yadav M; Parle M; Sharma N; Jindal DK; Bhidhasra A; Dhingra MS; Kumar A; Dhingra S Biomed Pharmacother; 2018 Sep; 105():1015-1025. PubMed ID: 30021336 [TBL] [Abstract][Full Text] [Related]
8. Protective effect of hesperetin against haloperidol-induced orofacial dyskinesia and catalepsy in rats. Dhingra D; Goswami S; Gahalain N Nutr Neurosci; 2018 Nov; 21(9):667-675. PubMed ID: 28641484 [TBL] [Abstract][Full Text] [Related]
9. Early Celastrol Administration Prevents Ketamine-Induced Psychotic-Like Behavioral Dysfunctions, Oxidative Stress and IL-10 Reduction in The Cerebellum of Adult Mice. Schiavone S; Tucci P; Trabace L; Morgese MG Molecules; 2019 Nov; 24(21):. PubMed ID: 31694174 [TBL] [Abstract][Full Text] [Related]
10. Antipsychotic activity of standardized Bacopa extract against ketamine-induced experimental psychosis in mice: Evidence for the involvement of dopaminergic, serotonergic, and cholinergic systems. Chatterjee M; Verma R; Kumari R; Singh S; Verma AK; Dwivedi AK; Palit G Pharm Biol; 2015; 53(12):1850-60. PubMed ID: 25856700 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the antipsychotic potential of Panax quinquefolium in ketamine induced experimental psychosis model in mice. Chatterjee M; Singh S; Kumari R; Verma AK; Palit G Neurochem Res; 2012 Apr; 37(4):759-70. PubMed ID: 22189635 [TBL] [Abstract][Full Text] [Related]
12. Effect of Shukla D; Maheshwari RA; Patel K; Balaraman R; Sen AK Indian J Pharmacol; 2018; 50(5):227-235. PubMed ID: 30636825 [TBL] [Abstract][Full Text] [Related]
13. Effect of 'chronic' versus 'acute' ketamine administration and its 'withdrawal' effect on behavioural alterations in mice: implications for experimental psychosis. Chatterjee M; Ganguly S; Srivastava M; Palit G Behav Brain Res; 2011 Jan; 216(1):247-54. PubMed ID: 20699106 [TBL] [Abstract][Full Text] [Related]
14. Ameliorative effect of Sida cordifolia in rotenone induced oxidative stress model of Parkinson's disease. Khurana N; Gajbhiye A Neurotoxicology; 2013 Dec; 39():57-64. PubMed ID: 23994302 [TBL] [Abstract][Full Text] [Related]
15. The inhibition of the kynurenine pathway prevents behavioral disturbances and oxidative stress in the brain of adult rats subjected to an animal model of schizophrenia. Réus GZ; Becker IRT; Scaini G; Petronilho F; Oses JP; Kaddurah-Daouk R; Ceretta LB; Zugno AI; Dal-Pizzol F; Quevedo J; Barichello T Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():55-63. PubMed ID: 29030243 [TBL] [Abstract][Full Text] [Related]
16. Morin Pretreatment Attenuates Schizophrenia-Like Behaviors in Experimental Animal Models. Ben-Azu B; Aderibigbe AO; Omogbiya IA; Ajayi AM; Iwalewa EO Drug Res (Stuttg); 2018 Mar; 68(3):159-167. PubMed ID: 28962045 [TBL] [Abstract][Full Text] [Related]
17. Brain targeted oral delivery of doxycycline hydrochloride encapsulated Tween 80 coated chitosan nanoparticles against ketamine induced psychosis: behavioral, biochemical, neurochemical and histological alterations in mice. Yadav M; Parle M; Sharma N; Dhingra S; Raina N; Jindal DK Drug Deliv; 2017 Nov; 24(1):1429-1440. PubMed ID: 28942680 [TBL] [Abstract][Full Text] [Related]
18. Alpha-lipoic acid alone and combined with clozapine reverses schizophrenia-like symptoms induced by ketamine in mice: Participation of antioxidant, nitrergic and neurotrophic mechanisms. Vasconcelos GS; Ximenes NC; de Sousa CN; Oliveira Tde Q; Lima LL; de Lucena DF; Gama CS; Macêdo D; Vasconcelos SM Schizophr Res; 2015 Jul; 165(2-3):163-70. PubMed ID: 25937462 [TBL] [Abstract][Full Text] [Related]
19. NEUROMODULATORY EFFECTS OF THYMOQUINONE IN EXTENUATING OXIDATIVE STRESS IN CHLORPROMAZINE TREATED RATS. Safhi MM Acta Pol Pharm; 2016; 73(2):529-35. PubMed ID: 27180446 [TBL] [Abstract][Full Text] [Related]
20. Effects of SB-269970, a 5-HT7 receptor antagonist, in mouse models predictive of antipsychotic-like activity. Galici R; Boggs JD; Miller KL; Bonaventure P; Atack JR Behav Pharmacol; 2008 Mar; 19(2):153-9. PubMed ID: 18332680 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]